FindTrial
Sign In

Clinicopathological features of drug-induced liver injury

Clinicopathological study of drug-induced liver injury

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2200060732
Enrollment
Unknown
Registered
2022-06-09
Start date
2022-06-01
Completion date
Unknown
Last updated
2024-06-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Drug induced liver injury

Interventions

Case series:None

Sponsors

The Third People's Hosptial of Zhenjiang
Lead Sponsor

Eligibility

Sex/Gender
All
Age
12 Years to 80 Years

Inclusion criteria

Inclusion criteria: 1. Drug-induced liver damage, liver histology samples (liver biopsy, surgical specimens, etc.); 2. The liver was compensated for liver disease; 3. Over 12 years old (adolescents and adults); 4. RUCAM >= 6 points.

Exclusion criteria

Exclusion criteria: 1. Merge HIV and other infectious diseases; 2. Malignant tumors.

Design outcomes

Primary

MeasureTime frame
liver function;liver stiffness measurement;demographic indicators;—

Secondary

MeasureTime frame
Outcomes (cured, improved, chronic);—

Countries

China

Contacts

Public ContactTan Youwen

The Third People's Hosptial of Zhenjiang

tyw915@sina.com+86 13914567088

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026